top of page
The Professional Network for Healthcare Experts
FDA approves Roche HER2 companion diagnostics for metastatic gastroesophageal adenocarcinoma
The FDA has expanded approval of two Roche HER2 companion diagnostics to identify patients with metastatic gastroesophageal adenocarcinoma who may be eligible for ZIIHERA treatment.
nuaxia
Sep 242 min read
ChemoMetec and Roche Diagnostics partner to integrate cell counting and bioprocess monitoring systems
The collaboration will connect ChemoMetec’s XcytoMatic 30 cell counter with Roche’s Cedex Bio Analyzer and establish a joint go-to-market strategy for the combined bioprocess monitoring solution.
nuaxia
Aug 112 min read
bottom of page